HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles J Rosser Selected Research

chlorzolamide

2/2009Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles J Rosser Research Topics

Disease

57Neoplasms (Cancer)
01/2022 - 08/2002
48Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 08/2002
42Prostatic Neoplasms (Prostate Cancer)
01/2019 - 08/2002
7Non-Muscle Invasive Bladder Neoplasms
01/2022 - 01/2014
6Carcinoma (Carcinomatosis)
01/2018 - 06/2003
4Hematuria
06/2021 - 11/2003
3Disease Progression
01/2021 - 11/2002
3Inflammation (Inflammations)
01/2019 - 10/2011
2Carcinogenesis
01/2020 - 07/2016
2Breast Neoplasms (Breast Cancer)
12/2018 - 01/2010
2Urinary Bladder Diseases (Bladder Diseases)
12/2016 - 06/2016
2Adenocarcinoma
03/2016 - 05/2007
2Ureteral Obstruction
01/2014 - 11/2003
2Paraganglioma (Paragangliomas)
04/2013 - 04/2013
2Neoplasm Metastasis (Metastasis)
01/2010 - 02/2009
2Margins of Excision
02/2009 - 11/2007
2Pain (Aches)
10/2006 - 11/2003
2Renal Cell Carcinoma (Grawitz Tumor)
06/2004 - 01/2004
1Infections
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2016
1Thrombosis (Thrombus)
03/2014
1Anemia
09/2013
1Skin Neoplasms (Skin Cancer)
07/2013

Drug/Important Bio-Agent (IBA)

37Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2009
31Proteins (Proteins, Gene)FDA Link
10/2021 - 09/2003
10Prostate-Specific Antigen (Semenogelase)IBA
12/2008 - 11/2002
6Plasminogen Activator Inhibitor 1IBA
01/2022 - 12/2013
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014 - 10/2007
5ALT-803IBA
01/2021 - 01/2014
5ChemokinesIBA
12/2019 - 07/2011
4Chemokine CXCL1IBA
01/2019 - 07/2013
4EnzymesIBA
02/2014 - 06/2011
4ImmunosorbentsIBA
02/2014 - 06/2011
3Interleukin-15 (Interleukin 15)IBA
01/2021 - 01/2019
3CarcinogensIBA
01/2020 - 01/2014
3Plasminogen Activators (Plasminogen Activator)IBA
01/2020 - 12/2013
3Interleukin-8 (Interleukin 8)IBA
12/2019 - 05/2012
3CytokinesIBA
12/2019 - 01/2014
3Monoclonal AntibodiesIBA
01/2019 - 07/2005
3AntigensIBA
12/2012 - 05/2012
3Pharmaceutical PreparationsIBA
01/2010 - 10/2007
3AndrogensIBA
08/2007 - 04/2003
2RNA (Ribonucleic Acid)IBA
12/2021 - 11/2019
2Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 07/2016
2Apolipoproteins E (ApoE)IBA
12/2019 - 11/2014
2angiogeninIBA
07/2016 - 05/2012
2Messenger RNA (mRNA)IBA
06/2016 - 06/2014
2ApolipoproteinsIBA
01/2013 - 12/2012
2Carbonic Anhydrase IXIBA
05/2012 - 10/2007
2Carrier Proteins (Binding Protein)IBA
04/2009 - 07/2005
2IsoflavonesIBA
05/2008 - 04/2007
2Biological ProductsIBA
05/2008 - 08/2006
2OligodeoxyribonucleotidesIBA
07/2007 - 01/2007
1Tuberculosis VaccinesIBA
01/2022
1ChromatinIBA
01/2022
1Cadherins (E-Cadherin)IBA
12/2021
1SerpinsIBA
01/2020
1Plasminogen Activator Inhibitor 2IBA
01/2020
1B7-H1 AntigenIBA
11/2019
1Coloring Agents (Dyes)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Claudin-2IBA
12/2018
1sphingosine kinaseIBA
12/2018
1SphingolipidsIBA
12/2018
1Epidermal Growth Factor (EGF)IBA
12/2018
1Estrogen ReceptorsIBA
12/2018
1MicroRNAs (MicroRNA)IBA
12/2016
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
07/2016
1Tyrosine (L-Tyrosine)FDA Link
02/2016
1Protein Isoforms (Isoforms)IBA
06/2014
1Laminin (Merosin)IBA
05/2014
1Matrix Metalloproteinases (MMPs)IBA
05/2014
1ElastinIBA
05/2014
1Small Interfering RNA (siRNA)IBA
05/2014
1CollagenIBA
05/2014
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2014
1Syndecan-1 (Syndecan 1)IBA
02/2014
1tiplaxtininIBA
12/2013
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
12/2013
1Antineoplastic Agents (Antineoplastics)IBA
12/2013
1ErythropoietinFDA Link
09/2013
1CXC ChemokinesIBA
07/2013
1LigandsIBA
07/2013

Therapy/Procedure

23Therapeutics
01/2022 - 08/2002
20Radiotherapy
01/2013 - 08/2002
12Prostatectomy (Retropubic Prostatectomy)
01/2019 - 05/2003
7Drug Therapy (Chemotherapy)
12/2021 - 01/2005
3Neoadjuvant Therapy
12/2021 - 06/2003
3Cystectomy
01/2014 - 06/2003
3Nephrectomy
01/2014 - 01/2004
2Immunotherapy
12/2021 - 11/2019
2Intravesical Administration
01/2014 - 08/2002
2Urinary Diversion (Ileal Conduit)
03/2005 - 06/2004
2Pelvic Exenteration
03/2005 - 11/2003
1Aftercare (After-Treatment)
01/2021
1Chemoprevention
12/2018
1Nephroureterectomy
01/2014
1Penile Prosthesis (Penile Implants)
01/2014
1Transurethral Resection of Prostate (TURP)
01/2014
1Lithotripsy (Extracorporeal Shockwave Lithotripsy)
01/2014